FindTrial
Sign In

Validation of an intelligent detection system for liver focal lesions: a multicentre study

A retrospective, multicentre, multi-reader, multi-case (MRMC) clinical trial evaluating software for the adjunctive detection of focal liver lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068636
Enrollment
Unknown
Registered
2023-02-26
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

focal liver lesion

Interventions

Gold Standard:Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study): In
Index test:an adjunct diagnostic software for focal liver lesion

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patient's age is greater than or equal to 18 years 2. Magnetic resonance technology meets the requirements 3. The necessary clinical information is complete

Exclusion criteria

Exclusion criteria: 1. Number of focal lesions of the same type in the liver exceeds 10 2. History of previous liver surgery or liver intervention 3. Severe, diffuse abnormalities in the background liver signal (e.g. due to severe cirrhosis, hepatic vascular disease, etc.)

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;positive predictive value;negative predictive value;time;accuracy rate;miss rates;misdiagnosis rate;Detection rates;—

Countries

China

Contacts

Public ContactYang Zhenghan

Beijing Friendship Hospital, Capital Medical University

yangzhenghan@vip.163.com13910831365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026